19th February 2015
InflectraTM (Infliximab) Patient Registry Reports Interim Results in the Treatment of Inflammatory Bowel Disease
Data have been presented on the use of Hospira’s Inflectra (infliximab) at the European Crohn’s and Colitis Organisation Inflammatory Bowel Diseases (ECCO-ibd) conference.
16th February 2015
Hospira Launches First Biosimilar Monoclonal Antibody (mAb) InflectraTM (Infliximab) in Major European Markets
LAKE FOREST, Ill., February 16, 2015 — Hospira, Inc. (NYSE: HSP), a world leader in the development of biosimilar therapies, today announced the launch…